Patient transport system enables and ensures on time delivery of medically ill, injured patients to health care organizations/institutions. Patient transport systems with significant resources and experienced staff have become an important and integral part of the health care sector. These systems are required by both critically ill, acute, chronic and non-urgent, planned patients for transport to and from hospitals, rehabilitation centers, clinics, nursing homes, and patient’s home. A patient transport system can be classified into two categories: emergency patient transport system and non-emergency patient transport system. The patient transport system market has experienced significant growth in the past few years and is expected to grow at a higher rate driven by increasing emphasis on improving value chain in the health care sector.
The global patient transport system market has been segmented into emergency patient transport system and non-emergency patient transport system. Emergency patient transport system has been further segmented into ground ambulance services, air ambulance services, and water ambulance services. Based on equipment required during transportation, nature of injury and illness, the patient transport system market has been classified into advanced critical life support ambulance, basic life support ambulance, neonatal ambulance, cardiac ambulance, mobile dialysis ambulance, mobile delivery vans, mobile operation theatres, and air ambulances. Non-emergency transport system provides trips to and from scheduled medical appointments, interdepartmental transfers, and transfers between hospitals. It includes basic life support ambulances, wheelchairs, stretchers, first responder services (two wheelers), mobile beds, etc. In developed countries such as the U.S. and countries in Europe air ambulance, advanced critical life support ambulance, neonatal ambulance, and cardiac ambulance will grow at higher rates as compared to other segments.
Advancement of technology in patient transport system, high demand for safety features, increasing pressure for shortest call response time, and increasing number of cardiac, neonatal, and road accident patients are expected to drive the global patient transport system market. Demand for specialty ambulances for neonatal, cardiac, and gynecology patients is expected to be the key driver of the global patients transport system market. Air ambulance system plays a crucial role in minimizing time for transportation especially from remote locations. Government policies on meeting quicker health care facilities especially in remote areas are also anticipated to contribute to the growth of the global patient transport system market. Increasing number of chronic patients globally, growing emphasis on safety and quality features, upcoming technology with ease of access and improved comfort level, and government policies and regulations in non-emergency medical transport have triggered the growth of the non-emergency patient transport segment. Rising cost of technology and safety standards in non-emergency patient transfer especially in developing countries are the key restraints of the segment.
Geographically, the global patient transport system market has been segmented into five regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America and Europe are the major markets for patient transport system owing to high expenditure on health care services and advancement of technologies. According to Wall Street Journal blog, countries such as the U.S., China, and Australia were able to transport 75% of seriously injured road accident patients to hospital, whereas this rate was only 10% to 49% in India, Japan, and Pakistan. This blog highlights the scope and opportunity for the growth of patient transport system in Asia Pacific, the Middle East, and Africa. The market in Asia Pacific is expected witness the highest growth rate due to increasing number of road accidents, rising number of patients, incremental growth in the health care sector, and growing pressure to shorten the call response time.
Key players providing patient transport systems are National Medtrans Network, Falck A/S, Air Methods Corporation, Envision Healthcare Corporation, Acadian, NSL Limited, Airmed International LLC, and Airpal, Inc. Falck A/S dominated the emergency patient transport market with expansion plan in Asia Pacific, while NSL Limited is largest private non-emergency ambulance service provider in the U.K.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.